Imagenebio, Inc. (IMA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Imagenebio, Inc., a Delaware corporation, on October 10, 2025. The company is an emerging growth company with its principal executive offices in San Diego, California. Its common stock trades on The Nasdaq Capital Market under the symbol "IMA".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the departure of a key executive officer:
- Resignation: Jotin Marango, M.D., Ph.D., resigned as Chief Financial Officer and principal financial officer.
- Effective Date: The resignation is effective October 20, 2025.
- Reason: The resignation was not due to any disagreement with the Company.
- Succession: The Company plans to conduct a search for Dr. Marango's replacement.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future operations, or specific risk factors beyond the operational impact of the CFO's departure. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Confirm the timeline for the appointment of a new Chief Financial Officer.
- Review the Company's interim financial reporting arrangements during the transition period.
- Monitor subsequent filings for any changes in the Company's financial strategy or capital structure following the leadership change.